Assessment of Fall Risk and Prevention of Falls in the Elderly

A fall is defined as an unexpected event in which the person comes to rest on the ground, floor, or lower level. Syncope and seizure must first be excluded by history.

About one-third of community-dwelling adults ≥65 years fall each year. Among nursing home residents, one in two falls each year. One in five falls causes serious injury such as fracture or head trauma.

In India, LASI wave-1 data show about 11.6% of adults ≥60 years report a fall, with higher rates in women and with advancing age; falls are heavily under-reported.

Complications include fractures of hip, femur, humerus, wrist and ribs, subdural haematoma (may present days to weeks later), immobility, fear of falling, loss of confidence, institutionalisation and death.

Falls are multifactorial — an acute trigger acting on accumulated chronic impairments. Rarely is a fall due to a single factor.

Age-related changes: reduced proprioception, slowed righting reflexes, increased antero-posterior postural sway, loss of type II (fast-twitch) fibres, stiffer joints. Gait speed declines 12–16% per decade.

Dual-tasking (walking while talking or counting) becomes difficult with age; institutionalised elders who cannot converse while walking have high fall risk.

Divided into intrinsic (ageing neuromuscular physiology, disease) and extrinsic (medications, environment). Risk rises exponentially as factors accumulate.

Useful mnemonic — AGAIN I'VE FALLEN: Again fallen (previous fall), Gait/balance problems, ADL loss, Impaired mental status, Number of drugs (>4), Illness/delirium, Vestibular disorders, Eyes/Ears, Foot disorders, Alcohol, Lower-limb weakness, Low BP (postural), Environmental hazards, Neurological disorders.

Medications are the commonest and most modifiable risk factor — benzodiazepines, Z-drugs, antipsychotics, all antidepressants (TCA/SSRI/SNRI), opioids, NSAIDs, muscle relaxants, antihistamines/anticholinergics, alpha-blockers, diuretics, antihypertensives, digoxin, amiodarone, insulin/sulphonylureas.

Risk is highest in the days to weeks immediately after starting a drug or changing its dose — start new drugs during periods of supervision and warn the patient.

Disease-related risk: dementia (2–8 times higher fall rate), stroke, Parkinson's disease, arthritis, peripheral neuropathy, chronic pain, orthostatic hypotension, carotid sinus hypersensitivity, urinary urgency and nocturia.

Fear of falling (FoF) is itself an independent predictor of future falls — it causes activity restriction, deconditioning and consumes cognitive reserve needed for gait.

Delirium is the leading cause of falls in hospital; environmental triggers include wet floors, poor lighting, loose rugs, clutter, steps and unstable furniture.

Screening (STEADI algorithm, CDC): ask every older adult whether they have fallen in the past year. Those who screen positive (or through the Stay Independent 12-item questionnaire / "three key questions") undergo full risk assessment.

History: exclude syncope/seizure, circumstances of the fall, relation to meals or medication, premonitory symptoms (palpitations, focal deficit), loss of consciousness, alcohol, and full drug list.

Examination: BP lying, sitting and standing (fall of >20 mmHg systolic = orthostatic hypotension), visual acuity, cardiac murmurs/arrhythmia/carotid sinus, neurological and cerebellar signs, joints, feet and footwear, and inspection of walking aids for defects.

Performance-based tests (must know):

Gait speed over 4 m — <0.6 m/sec is abnormal; every 0.1 m/sec fall in speed = 7% rise in fall risk

Timed Get Up and Go Test (GUGT/TUG) — >12 seconds = high risk (sensitivity 77%, PPV 93%)

30-second chair stand and 4-stage balance test

Tinetti Mobility Scale (POMA) — score <24/28 indicates fall risk

Berg Balance Scale (0–56) and Short Physical Performance Battery (SPPB) (0–12)

Investigations: no routine laboratory or imaging tests are needed. Minimum work-up is lying/standing BP and a 12-lead ECG. MRI only if a treatable neurological cause is suspected (infarcts, hydrocephalus, cerebellar degeneration); EEG only with strong suspicion of seizure.

Multifactorial, targeted intervention is the cornerstone:

Exercise (best evidence): balance and functional exercise reduces fall rate by 24%; multiple exercise types (balance + resistance) by 34%; Tai chi by 19%. Walking alone or resistance training alone is of uncertain benefit.

Medication review and withdrawal of psychotropics — proven to reduce falls.

Home hazard assessment and modification, most effective when done by an occupational therapist (grab bars, lighting, removing rugs, raising bed/chair height).

Vision: cataract surgery (first eye) reduces falls; replace multifocal with single-vision lenses for outdoor use.

Vitamin D: benefit mainly in those with low baseline levels and in nursing-home residents.

Cardiac pacing for cardioinhibitory carotid sinus hypersensitivity.

Hip protectors: small benefit in care homes (RR 0.82); no clear benefit in the community; adherence is poor.

In hospital/nursing homes: prevent and treat delirium. Physical restraints, bed rails and bed alarms do NOT reduce falls and may cause harm.

World Falls Guidelines (Age and Ageing) — three-tier risk stratification, now the global standard. Older adults are stratified into low risk (education and general exercise), intermediate risk (targeted exercise or physiotherapy referral for balance and strength), and high risk (full multifactorial falls risk assessment with individualised tailored interventions). High-risk features include recurrent falls, injurious falls, frailty and balance problems.

NICE NG249 (April 2025) — replaces the 2013 CG161 guideline. It covers everyone aged 65 and over, plus people aged 50–64 who are at higher risk. Key shifts:

Do not use formal falls risk-prediction tools. Instead, directly ask all people ≥65 (and 50–64 with risk-enhancing conditions such as dementia, arthritis, Parkinson's disease, stroke, diabetes or learning disability) about any fall in the past year.

Comprehensive falls assessment is offered to those meeting defined criteria, including two or more falls in the last year; those who fell once without these criteria have their gait and balance assessed.

Offer a home hazard assessment using a validated tool, preferably delivered by an occupational therapist; consider cognitive behavioural interventions where concern about falling is not helped by strength and balance exercises; investigate carotid sinus hypersensitivity and consider cardiac pacing for unexplained falls.

Vitamin D is not recommended specifically to reduce falls — evidence is insufficient — though people are encouraged to take it for bone and muscle health.

USPSTF 2024 (JAMA) — exercise upgraded, multifactorial downgraded. Exercise interventions are recommended (Grade B) to prevent falls in community-dwelling adults ≥65 at increased risk. The decision to offer multifactorial interventions must be individualised (Grade C), weighing prior falls, comorbidities and patient preference, because the overall net benefit of routinely offering them is small.

USPSTF draft statement (December 2024) — vitamin D for falls. A Grade D (recommend against) was proposed for vitamin D, with or without calcium, to prevent falls or fractures in community-dwelling postmenopausal women and men ≥60 years. This does not apply to those with diagnosed osteoporosis or vitamin D deficiency.

Cochrane Review 2025 (Dyer et al., CD016064) — care facilities. Multifactorial interventions implemented with facility staff engagement and tailored to individual residents probably reduce the rate of falls and risk of falling, and may be cost-effective; among single interventions, exercise probably reduces falls. Vitamin D supplementation also likely reduces falls in care facilities, and increasing dietary dairy servings may reduce the number of people falling.

STOP-FALLS trial (JAMA Network Open, 2024) — deprescribing alone is not enough. In 2,367 older adults, a health-system-embedded deprescribing intervention targeting CNS-active medications (opioids, benzodiazepines/Z-drugs, muscle relaxants, TCAs, first-generation antihistamines) did not significantly reduce medically treated falls compared with usual care; modest prescribing improvements occurred without a measurable effect on clinical outcomes.

STOPPFall (EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs). A validated Delphi-derived tool listing 14 medication classes (mostly psychotropics) that increase fall risk, combined with practical stepwise deprescribing guidance. This is now the preferred structured framework for FRID review.

Indian evidence (LASI wave-1 analyses, 2022–2026). 11.6% of Indian older adults report falls, higher in women and with advancing age; independent determinants are female sex, underweight BMI, tobacco/alcohol use, chronic joint disease, prior injury or fracture, sensory impairment, depression, ADL limitation and poor physical performance. Environmental and drug factors dominate — slippery floors (OR 2.28), polypharmacy (OR 1.71), hearing loss (OR 1.83) and depression (OR 1.62). Frail older Indians have higher falls (15.4% vs 11.9%), multiple falls (7.7% vs 5.3%) and fall-related injuries (6.7% vs 5.3%) than non-frail.

Indian service delivery. Fall risk screening is delivered through NPHCE — geriatric clinics at PHC/CHC level, rehabilitation units and physiotherapy at district hospitals, Regional Geriatric Centres, and domiciliary visits by rehabilitation workers for bed-bound elders. Assistive devices and mobility aids are supplied through ADIP/RVY via ALIMCO and DDRCs.

Emerging directions (2023–2026). Sensory impairment — especially hearing loss and dizziness — is being proposed for inclusion in risk-stratification algorithms. Modified algorithms using a shorter TUG cut-point (10 seconds) are being tested to improve stratification into the intermediate-risk group. Wearable fall-detection devices and tele-rehabilitation are expanding access where multifactorial clinics are unavailable.

Fall = unexpected event coming to rest on ground/floor/lower level.

One-third of community elders and one-half of nursing-home residents fall yearly; 1 in 5 falls injures.

India (LASI): 11.6% prevalence; slippery floors, polypharmacy, hearing loss and depression are key drivers.

Mnemonic: AGAIN I'VE FALLEN.

Medications = most modifiable risk factor; danger window is immediately after starting or changing a drug.

Gait speed <0.6 m/sec abnormal; 0.1 m/sec drop = 7% ↑ risk.

TUG >12 seconds = high fall risk.

Tinetti POMA <24/28 = fall risk.

Orthostatic hypotension = fall of >20 mmHg systolic on standing.

No routine labs; minimum = lying/standing BP + 12-lead ECG.

Delirium = leading cause of inpatient falls.

Balance + functional exercise ↓ falls 24%; multiple exercise types ↓ 34%; Tai chi ↓ 19%.

Restraints, bed rails and bed alarms do NOT prevent falls.

Hip protectors — modest benefit in care homes (RR 0.82), none in the community.

Cardiac pacing for cardioinhibitory carotid sinus hypersensitivity with unexplained falls.

NICE NG249 (2025): do not use falls risk-prediction tools.

USPSTF 2024: exercise = Grade B; multifactorial = Grade C.

STOPPFall = 14 fall-risk-increasing drug classes.

Fear of falling is both a consequence and an independent predictor — treat with CBT.